Sedana Medical: Exercise of warrants in incentive program 2017/21
Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that all warrants in the company's incentive program 2017/21 have been exercised by the warrant holders, leading to an increase in the number of shares and votes in the company by 310,149. Accordingly, the share capital is increased by approximately SEK 31,015. Through the exercise of the warrants, Sedana Medical’s CEO, CFO and CMO have increased their ownership in the company. Further, the mentioned senior executives have sold part of the shares subscribed in order to finance the exercise of the warrants and future tax effects